The effects of different intensity walking programs on serum blood lipids, high-sensitive C-reactive protein, and lipoprotein-associated phospholipase A2 in premenopausal women;Effets de programmes de marche de différentes intensités sur les lipides sériques, la protéine C réactive ultrasensible et la phospholipase A2 associée à une lipoprotéine chez des femmes pre

Science and Sports

Volumn 25, Issue 5, 2010, Pages 245-252

  Buyukyazi, G ^a   Ulman, C ^a   Taneli, F ^a   Esen, H ^a   Gozlukaya, F ^a   Ozcan, I ^a   Tikiz, H ^a  

^a CELAL BAYAR UNIVERSITY   (Turkey)

Author keywords

High sensitive C reactive protein; Lipoprotein associated phospholipase A2; Premenopausal; Serum lipids; Walking

Indexed keywords

C REACTIVE PROTEIN; LIPOPROTEIN; PHOSPHOLIPASE A2;

ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE INTENSITY; FEMALE; HEALTH PROGRAM; HEART RATE; HUMAN; LIPID BLOOD LEVEL; LIPID DEGRADATION; OXYGEN CONSUMPTION; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; WALKING; WOMEN'S HEALTH;

EID: 78249270448     PISSN: 07651597     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.scispo.2010.01.002     Document Type: Article

References (40)

1. Abramson J.L., Vaccarino V. Relationship between physical activity and inflammation among apparently healthy middle-aged and older US adults. Arch Intern Med 2002, 162(11):1286-1292.
2. American College of Sports Medicine: ACSM's guidelines for exercise testing and prescription. Ed. 6. Philadelphia, Lippincott Williams & Wilkins, 2000.
3. Ballantyne C.M., Hoogeveen R.C., Bang H., Coresh J., Folsom A.R., Heiss G., et al. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident heart disease in middleaged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Circulation 2004, 109:837-842.
4. Bassuk S.S., Rifai N., Ridker P.M. High-sensitivity C-reactive protein: Clinical importance. Curr Probl Cardiol 2004, 9:439-493.
5. Berkeley nutrition services. Free dietary screeners. Retrieved 15 February 2009, from: http://www.nutritionquest.com/.
6. Blair S.N., Kohl H.W., Paffenbarger R.S., Clark D.G., Cooper K.H., Gibbons L.W. Physical fitness and all-cause mortality: A prospective study of healthy men and women. JAMA 1989, 262:2395-2401.
7. Bouchard C., Despres J.-P., Tremblay A. Exercise and obesity. Obes Res 1993, 1:133-147.
8. Boyden T.W., Pamenter R.W., Rotkis T.C., Morrison D.A., Freund B.J., Stanforth P.R., et al. Effects of exercise training on plasma cholesterol, high-density lipoprotein cholesterol and sex steroid concentrations in women. Coronary heart disease in women 1987, 158-163. Haymarket Doyma Inc, New York. E.D. Baker, B. Packard, N.K. Wenger, T.B. Clarkson, H.A. Tyroler (Eds.).
9. Church T.S., Barlow C.E., Earnest C.P., Kampert J.B., Priest E.L., Blair S.N. Associations between cardiorespiratory fitness and C-reactive protein in men. Arterioscler Thromb Vasc Biol 2002, 22:1869-1876.
10. Criswell D., Powers S., Dodd S., Lawler J., Edwards W. High intensity training-induced changes in skeletal muscle antioxidant enzyme activity. Med Sci Sports Exerc 1993, 25:1135-1140.
11. Despres J.P., Lamarche B. Low-intensity endurance exercise training, plasma lipoproteins, and the risk of coronary heart disease. J Int Med Res 1994, 236:7-22.
12. Fallon K.E., Fallon S.K., Boston T. The acute phase response and exercise: Court and field sports. Br J Sports Med 2001, 35:170-173.
13. Ford E.S. Does exercise reduce inflammation? Physical activity and C-reactive protein among US adults. Epidemiology 2002, 13(5):561-568.
14. Garza C.A., Montori V.M., McConnell J.P., Somers V.K., Kullo I.J., Lopez- Jimenz F. Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: A systematic review. Mayo Clin Proc 2007, 82:159-165.
15. Geffken D.F., Cushman M., Burke G.L., Polak J.F., Sakkinen P.A., Tracy R.P. Association between physical activity and markers of inflammation in a healthy elderly population. Am J Epidemiol 2001, 153:242-250.
16. Gonzales M.A., Selwyn A.P. Endothelial function, inflammation, and prognosis in cardiovascular disease. Am J Med 2003, 115(Suppl 8A):99S-106S.
17. Hakkinen T., Luoma J.S., Hiltunen M.O., Macphee C.H., Milliner K.J., Patel L., et al. Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions. Arterioscler Thromb Vasc Biol 1999, 19:2909-2917.
18. Hardman A.E., Hudson A. Brisk walking and serum lipid and lipoprotein variables in previously sedentary women - effect of 12 weeks regular brisk walking followed by 12 weeks of detraining. Br J Sports Med 1994, 28:261-266.
19. Haskell W.L. The influence of exercise training on plasma lipid and lipoproteins in health and disease. Physical activity in health and disease 1986, 25-37. Almqvist and Wiksell International, Stockholm. P.O. Astrand, G. Grimby (Eds.).
20. Hubinger L., Mackinnon L.T., Lepre F. Lipoprotein(a) [Lp(a)] levels in middle-aged male runners and sedentary controls. Med Sci Sports Exerc 1995, 27(4):490-496.
21. Jakicic J.M., Clark K., Coleman E., Donnelly J.E., Foreyt J., Melanson E., et al. American College of Sports Medicine position stand. Appropriate intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc 2001, 33:2145-2156.
22. 2 is highly expressed in macrophages of coronary lesions prone to rupture. Circulation 2004, 110(Suppl III):246-247.
23. Kolodgie F.D., Burke A.P., Skorija K.S., Ladich E., Kutys R., Makuria A.T., et al. Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis. Arterioscler Thromb Vasc Biol 2006, 26:2523-2529.
24. Koenig W., Khuseyinova N., Löwel H., Trischler G., Meisinger C. Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: Results from the 14-year follow-up of a large cohort from southern Germany (MONICA-Augsburg). Circulation 2004, 110:1903-1908.
25. Laukkanen R., Oja P., Pasanen M., Vuori I. Validity of a two kilometer walking test for estimating maximal aerobic power in overweight adults. Int J Obes Relat Metab Disord 1992, 16(4):263-268.
26. Lavi S., McConnell J.P., Rihal C.S., Prasad A., Mathew V., Lerman L.O., et al. Local production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: Association with early coronary atherosclerosis and endothelial dysfunction in humans. Circulation 2007, 115:2715-2721.
27. Leon A.S., Wilmore J.H., Gaew Y., Rankinen T.S., Rao D.C., Skinner J., et al. Endurance Exercise TVaining Reduces Lp-PLA2 in Young White Adults: The HERITAGE Family Study. Med Sci Sports Exerc 2007, 39(5):S312.
28. Mann P.J., Williams D.P., Snow C.M., Wonder R.C. Physical activity, body fat, and serum C-reactive protein in postmenopausal women with and without hormone replacement. Am J Hum Biol 2003, 15(1):91-100.
29. Mattusch F., Dufaux B., Heine O., Mertens I., Rost R. Reduction of the plasma concentration of C-reactive protein following nine months of endurance training. Int J Sports Med 2000, 21:21-24.
30. Monzillo L.U., Hamdy O., Horton E.S., Ledbury S., Mullooly C., Jarema C., et al. Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance. Obes Res 2003, 11(9):1048-1054.
31. Morris R., Digenio A., Padayachee G.N., Kinnear B. The effect of a 6-month cardiac rehabilitation program on serum lipoproteins and apoproteins A1 and B and lipoprotein A. S Afr Med J 1993, 83:315-318.
32. Oja P., Laukkanen R., Pasanen M., Tyry T., Vuori I. A 2-km walking test for assessing the cardiorespiratory fitness of healthy adults. Int J Sports Med 1991, 12(4):356-362.
33. Park S.K., Park J.H., Kwon Y.C., Yoon M.S., Kim C.S. The effect of long-term aerobic exercise on maximal oxygen consumption, left ventricular function and serum lipids in elderly women. J Physiol Anthropol 2003, 22(1):11-17.
34. Ridker P.M., Buring J.E., Shih J., Matias M., Hennekens C.H. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998, 98:731-733.
35. Ridker P.M., Stampfer M.J., Rifai N. Novel risk factors for systemic atherosclerosis: A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 2001, 285:2481-2485.
36. Ridker P.M. High-sensitivity C-reactive protein and cardiovascular risk: Rationale for screening and primary prevention. Am J Cardiol 2003, 92:17K-22K.
37. Smith J.K., Dykes R., Dougles J.E., Krishnaswamy G., Berk S. Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease. JAMA 1999, 281:1722-1727.
38. Williford H.N., Blessing D.L., Barksdale J.M., Smith F.H. The effects of aerobic dance training on serum lipids, lipoproteins, and cardiopulmonary function. J Sports Med Phys Fitness 1988, 28:151-157.
39. Wood P.D., Stefanick M.L., Williams P., Haskell W.L. The effects of plasma lipoproteins of a prudent weight-reducing diet with or without exercise, in over-weight men and women. N Engl J Med 1991, 325:561-566.
40. Wootton P.T.E., Flavell D.M., Montgomery H.E., World M., Humphries S.E., Talmud P.J. Lipoprotein-associated phospholipase A2 A379V variant is associated with body composition changes in response to exercise training. Nutr Metab Cardiovasc Dis 2007, 17:24-31.